71
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study

, , , , , & show all
Pages 1233-1243 | Published online: 08 Jun 2016

References